Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Platform Trial to Evaluate Therapeutics in Patients With Moderate or Severe Dengue (DEN-HOST)

NCT07543458 is registered in ClinicalTrials.gov with Oxford University Clinical Research Unit, Vietnam as lead sponsor.

NCT NCT07543458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07543458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Platform Trial to Evaluate Therapeutics in Patients With Moderate or Severe Dengue (DEN-HOST)
Lead sponsor
Oxford University Clinical Research Unit, Vietnam
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
July 31, 2031
Enrollment
8,800 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

arbovirus infections, dengue, flavivirus infections, hemorrhagic fever, mosquito-borne diseases, rna virus infections, severe dengue, vector borne diseases